EMA Recommends Granting a Marketing Authorisation for Nirogacestat By Ogkologos - July 3, 2025 311 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with progressing desmoid tumours Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR The most important cancer research stories of 2022 December 14, 2022 Targeted Radiation Reduces Pain from Cancer Metastases in the Spine November 24, 2020 Revumenib Shows Promise in Treating Advanced Acute Myeloid Leukemia April 18, 2023 Cancer in My Community: Bringing Palliative Care to People With Cancer... February 21, 2023 Load more HOT NEWS Remembering With Gratitude Woman Suffers Seizure And Dies After Making Fatal Error With Her... ¿Las gammagrafías óseas muestran el cáncer? EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with...
